Fabtech Technologies FY26 Revenue Surges 28% to ₹431 Cr on Strong Order Book
Fabtech Technologies Ltd reported a significant 28.4% year-on-year jump in total income for FY26, reaching ₹431.33 crore.
The company bolstered its future revenue visibility with a robust consolidated order book exceeding ₹900 crore as of March 31, 2026.
Reader Takeaway: Revenue soared on global project wins; execution risks remain amidst market volatility.
What just happened (today’s filing)
Fabtech Technologies announced strong financial results for the fiscal year ended March 31, 2026.
Total income surged by 28.4% year-on-year to ₹431.33 crore. This growth was complemented by a healthy consolidated order book standing at over ₹900 crore as of March 31, 2026.
Operationally, the company achieved a significant turnaround, swinging to positive operating cash flow of ₹0.48 crore in FY26 from a negative ₹36.15 crore in FY25.
Further strengthening its balance sheet, current borrowings were reduced to ₹42.20 crore from ₹54.09 crore in the previous fiscal year.
Why this matters
The results highlight Fabtech's successful execution of its growth strategy, focusing on complex, high-value projects.
Expansion into high-growth geographies like Saudi Arabia and Africa, alongside diversification into the animal health segment, are key drivers for future revenue streams.
The company's emphasis on in-house manufacturing capabilities is expected to enhance project execution efficiency and profitability.
The backstory (grounded)
Fabtech Technologies has been actively expanding its international footprint, securing key contracts in strategic regions. [cite:groundedResearch.backstory[0]]
These include a USD 7.05 million OSD Facility project in West Africa and a USD 7.8 million Animal Vaccine project in Saudi Arabia. [cite:groundedResearch.backstory[0]]
A significant veterinary facility project in North Africa, valued between ₹49–52 crore, is also part of this international push. [cite:groundedResearch.backstory[0]]
What changes now
Shareholders can anticipate increased revenue visibility due to the substantial order book.
The company's strengthened global presence offers diversification benefits, reducing reliance on any single market.
Improved financial health, marked by positive operating cash flow and debt reduction, positions Fabtech for sustainable growth.
Risks to watch
Future performance remains subject to risks including fluctuations in revenue, income, and cash flows.
The successful implementation of its strategy and future growth levels are dependent on execution capabilities.
Performance is also susceptible to broader economic conditions in India and international markets, as well as industry trends and competition.
Peer comparison
Fabtech operates in the engineering, procurement, and construction (EPC) sector, a domain populated by major players. [cite:groundedResearch.companySnapshot[0]]
Peers such as Larsen & Toubro, KNR Constructions, and PNC Infratech also compete in various infrastructure and industrial segments. [cite:groundedResearch.peerSet[0], groundedResearch.peerSet[1], groundedResearch.peerSet[2]]
Fabtech's recent focus on specialized international projects and the animal health segment differentiates its strategic direction within this competitive landscape.
Context metrics (time-bound)
- Consolidated Total Income grew by 28.4% from ₹335.94 Cr in FY25 to ₹431.33 Cr in FY26.
- Consolidated EBITDA saw an increase of 18.29% from ₹46.97 Cr in FY25 to ₹55.56 Cr in FY26.
- Consolidated Operating Cash Flow swung from -₹36.15 Cr in FY25 to ₹0.48 Cr in FY26.
- Consolidated Current Borrowings decreased from ₹54.09 Cr in FY25 to ₹42.20 Cr in FY26.
What to track next
Monitor the progress and execution of large-scale pharma and infrastructure projects in Africa.
Watch for updates on expansion and execution in Saudi Arabia for vaccine and advanced pharma projects.
Track the timely completion of the North Africa veterinary facility targeted for Q1 FY27.
Observe continued revenue growth and market expansion initiatives in MENA, GCC, and ECO Zone markets.
